Frontlight ResearchEarly access
Trial site
Columbus Regional Research Institute
- 4running trials
- 5closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)2 trials
- Acute myeloid leukaemia1 trial
- Asthma1 trial
- Atopic dermatitis (eczema)1 trial
- Atrial fibrillation1 trial
- Colorectal cancer1 trial
- Head and neck cancer1 trial
- Heart failure1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Status
- Active, not recruiting3 trials
- Completed3 trials
- Terminated2 trials
- Recruiting1 trial
- Lead sponsor
- Pfizer2 trials
- Boehringer Ingelheim1 trial
- Celgene1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- Guardant Health, Inc.1 trial
- and 3 more
Running trials
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Active, not recruiting
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure1 recruiting
Closed trials
Terminated
Completed
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
Completed
Completed
Terminated
Site data: ClinicalTrials.govUpdated 17 Nov 2026